Related Experiment Videos
Significance of reduction in heart rate in cardiovascular disease
1University of Göteborg, Sweden.
Insights
Lowering heart rate is linked to reduced cardiovascular and overall mortality. This finding suggests that decreasing heart rate should be a key therapeutic goal for cardiovascular disease management.
Area of Science:
- Cardiology
- Pharmacology
- Epidemiology
Background:
- Lower heart rate is associated with decreased cardiovascular and all-cause mortality.
- Heart rate is an independent predictor of outcomes following myocardial infarction (MI).
- Increased heart rate exacerbates myocardial ischemia, angina, and MI size in patients with coronary artery disease.
Purpose of the Study:
- To evaluate the role of heart rate reduction as a therapeutic target in cardiovascular disease.
- To analyze the relationship between heart rate reduction and mortality outcomes.
- To assess the efficacy of pharmacologic interventions in modifying heart rate and improving patient outcomes.
Main Methods:
- Review of epidemiologic studies and clinical trials involving pharmacologic interventions.
- Analysis of data correlating heart rate reduction with mortality and morbidity after myocardial infarction.
- Comparison of outcomes associated with beta blockers and calcium antagonists in cardiovascular disease management.
Main Results:
- Pharmacologic interventions like beta blockers that reduce heart rate generally improve outcomes and reduce mortality post-MI.
- A nearly linear relationship exists between heart rate reduction and mortality reduction with most beta blockers.
- Evidence for calcium antagonists is mixed, potentially due to effects on myocardial contractility.
Conclusions:
- Reduction in heart rate is a significant therapeutic goal in managing cardiovascular disease.
- Heart rate lowering strategies, particularly with beta blockers, demonstrate clear benefits in reducing mortality.
- Further research may be needed to clarify the role of other heart rate-lowering agents.
Abstract:
Epidemiologic studies suggest that lower heart rate is associated with decreased cardiovascular and all-cause mortality. Heart rate has also been reported to be an independent predictor of outcome after myocardial infarction (MI). Because it is a major determinant of oxygen consumption and metabolic demand, a decrease in heart rate would be expected to decrease cardiac workload. Among patients with restricted coronary blood flow, increased heart rate is associated with more severe myocardial ischemia, angina, and an increase in size of MI. Pharmacologic interventions that reduce heart rate, such as beta blockers, generally reduce mortality and improve outcome. A number of clinical trials using beta blockers after MI has shown a relationship between reduction in heart rate and reduction in mortality. Most beta blockers demonstrate a nearly linear relationship between reductions in mortality and in heart rate. The evidence from trials with calcium antagonists is more equivocal, possibly because until very recently none were available that decreased heart rate without decreasing myocardial contractility. Drugs that do not reduce the heart rate after an MI and in congestive heart failure have not been found to improve survival. In light of the findings thus far reported, reduction in heart rate should be a therapeutic goal in the treatment of cardiovascular disease.